More than 75m customers
Surpassed €250m in annual revenue
More than 8m Devices Sold
Crossed the $200m ARR mark
IPO Market Cap at £1bn
Treated over 700,000 patients
IPO’d at nearly £9bn
$35.8b closing price post IPO
We invest in the people building what’s next. From fintech and AI to climate and quantum, our portfolio spans over 100 companies shaping the future of European technology. Together, they’re redefining what’s possible.
More than 75m customers
Surpassed €250m in annual revenue
More than 8m Devices Sold
Crossed the $200m ARR mark
IPO Market Cap at £1bn
Treated over 700,000 patients
IPO’d at nearly £9bn
$35.8b closing price post IPO